Category: news

Meet the Team: Andro Hsu

Andro is 23andMe's science and policy liaison. His main responsibility is to monitor opinion in policy, regulatory, academic, and other stakeholder circles, and to integrate this feedback into 23andMe's product and internal procedures. Recently, he worked on 23andMe's successful application for a California ...

Read more

A New Way to View Your Data

23andMe is always looking for ways not just to give our customers more data, but to help them better understand their genetic information and what it means for them. This week, we're introducing a new way to look at Health and Traits data that does just that by pinpointing for each person the particular ...

Read more

Meet the Team: Marcela

Meet Marcela, a product manager at 23andMe. A product manager represents the customer’s needs while also considering engineering constraints and business requirements. Her most recent projects were focused on building the user experience of those who participate in research through 23andWe and helping to ...

Read more

Plus ca change … The Mystery of Ultraconserved Elements

Before efforts to sequence the human genome began, scientists thought they’d find about 100,000 protein coding genes in the three billion bases pairs of DNA that are found in almost every cell. But much to everyone’s surprise, the true number turned out to be much lower. It’s now thought that the human ...

Read more

23andMe Co-founders Announce Breast Cancer Initiative

23andMe is marking the 23rd anniversary of National Breast Cancer Awareness Month this October with an initiative to build a web-based forum dedicated to helping women who face the disease. Co-founders Linda Avey and Anne Wojcicki told science and business leaders at Fortune's Most Powerful Women Summit ...

Read more

Biotech Company Applies for FDA Permission to Market Gene-Targeted Heart Failure Drug

Researchers are sometimes frustrated when a prospective drug proves effective in some patients, but not enough to justify giving it to everyone who has the condition it is intended to treat. The beta-blocker drug bucindolol met that fate in 2001 when it was originally tested as a treatment for heart ...

Read more

What it Means to be Human

What is it about humans that distinguishes us from the rest of the animal kingdom?  Is it our upright walking?  Our language?  Our love of Reality TV?  Even though we are said to be 99% genetically identical to our closest evolutionary relative, the chimpanzee, we clearly differ vastly from them physically ...

Read more

Google Co-Founder Blogs About 23andMe Data, Parkinson’s Risk

Already well-known for expanding technological frontiers, Google co-founder Sergey Brin is now pushing the boundaries of personal genomics with a remarkable post on his new personal blog, TOO. In the post, Brin shares information from his 23andMe account that indicates he is at substantially increased risk ...

Read more

New Study Looks at Progress and Potential for Genomic Medicine in Developing Nations

A special supplement to Nature Reviews Genetics, published online today, details how four countries with emerging economies – Mexico, India, Thailand and South Africa – are taking steps to build capacity for studies of human genomic variation and its applications to healthcare. Following completion of the ...

Read more

Surgeon General Issues Call to Action on VTE: 23andMe Assesses Genetic Risk for Customers

This Monday acting Surgeon General Steven K. Galson issued a Call to Action to reduce the number of people in the United States affected by two serious blood clotting conditions: deep vein thrombosis and pulmonary embolism. Deep vein thrombosis (DVT), sometimes called “economy class syndrome” is the ...

Read more

Return to top